Dual targeting of CDK4/6 and Bcl-2 exhibits a potent antitumor effect on mantle cell lymphoma

Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine

Lawrence M. Gelbert, Shufen Cai, Xi Lin et al. · Investigational New Drugs · 2014 · 565 citations · Full text

Medicine, Oncology, Pharmacology +17

Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma

Constantine S. Tam, Mary Ann Anderson, Christiane Pott et al. · New England Journal of Medicine · 2018 · 429 citations

Medicine, Pharmacology, Pharmacotherapy +13

Increased survival after treatments with anticancer agents of Chinese hamster cells expressing the human Mr 27,000 heat shock protein.

Jacques Huot, G.L. Roy, Herman Lambert et al. · PubMed · 1991 · 223 citations

Medicine, Oncology, Pharmacology +13

Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling

Itziar Salaverría, Lluı́s Armengol, Magda Pinyol et al. · Blood · 2008 · 181 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

HE4 (WFDC2) gene overexpression promotes ovarian tumor growth

Richard G. Moore, Emily K. Hill, Timothy C. Horan et al. · Scientific Reports · 2014 · 102 citations · Full text

Medicine, Molecular Biology, Oncology +17